Opioid pharmacotherapy in criminal justice settings: Now is the time

Substance Abuse

Volumn 33, Issue 1, 2012, Pages 1-4

  Lee, Joshua D ^a   Rich, Josiah D ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRIMINAL LAW; EDITORIAL; HUMAN; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PRISON;

CRIMINAL LAW; HUMANS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRISONS;

EID: 84856867111     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.616797     Document Type: Review

References (11)

1. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD.Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-88.
2. Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301:183-190.
3. Magura S, Rosenblum A, Joseph H. Evaluation of in-jail methadone maintenance: preliminary results. NIDA Res Monogr. 1992;118:192-210.
4. Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O'Grady KE. A randomized clinical trial ofmethadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37:277-285.
5. Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, Rosenblum A. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99:222-230.
6. Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. J Gen Intern Med. 2009;24:226-232.
7. Wang EA, Moore BA, Sullivan LE, Fiellin DA. Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. J Gen Intern Med. 2010;25:670-674.
8. Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extendedrelease naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011;377:1506-1513.
9. Dole VP, Nyswander ME, Warner A. Successful treatment of 750 criminal addicts. JAMA. 1968;206:2708-2711.
10. Dole VP, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280:1372-1375.
11. Dole VP. Detoxification of sick addicts in prison. JAMA. 1972;220:366-369.